SOLVD Health Announces FDA Approval to Expand AvertD® Sample Collection to Include Blood, Enabling Broad Availability of the First and Only FDA‑Approved Genetic Test ...

SOLVD Health, a privately held company focused on preventing disease through actionable and personalized health information, today announced broad availability of AvertD® following FDA approval to ...
McKnight's Long-Term Care News

Study: It’s time to update hospital readmission risk assessment tools for SNFs

A new study calls for updating the tools used to assess hospital readmission risk for skilled nursing facility (SNF) residents. One of the measurements used to assess a SNF’s quality of care is how ...
National Academies of Sciences%2c Engineering%2c and Medicine

Building Confidence in New Evidence Streams for Human Health Risk Assessment: Lessons Learned from Laboratory Mammalian Toxicity Tests

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF. New approach methods (NAMs) include nonanimal and other approaches, such as ...
Health Affairs

Risk Adjustment Reform: Navigating Ideas And Tradeoffs (Part 2)

These efforts include home-based health risk assessments and intensive review of medical records. Furthermore, there are other important objectives that would be supported by such data collection, e.g ...

SOLVD Health Announces FDA Approval to Expand AvertD(R) Sample Collection to Include Blood, Enabling Broad Availability of the First and Only FDA--Approved Genetic Test ...

SOLVD Health, a privately held company focused on preventing disease through actionable and personalized health information, today announced broad availability of AvertD(R) following FDA approval to ...